by Peter Kapitein | Jun 16, 2017 | In the media
I was struck by a press announcement of the FDA of May 23rd: ‘FDA approves first cancer treatment for any solid tumour with a specific genetic feature’. This is good news. Because it means that the knowledge that science has given us many years ago now is accepted by...
by Peter Kapitein | Apr 27, 2017 | In the media
On March 28th I attended an excellent congress of the European Alliance of Personalized Medicine (EAPM) about lung cancer screening. Lectures and discussions had a very high level. But something was missing. For the man with the hammer the whole world looks like a...
by Peter Kapitein | Apr 6, 2017 | In the media
CCO – Drugs that really work
by Peter Kapitein | Apr 6, 2017 | In the media
Ethical, Legal, and Counseling Challenges Surrounding the Return of Genetic Results in Oncology.full
by Peter Kapitein | Apr 6, 2017 | In the media
HMM – Does more value naturally lead to beter care?
